Physician profile
Michael Rothberg
NPI 1861498628
$8,273.35
in general payments reported to CMS, 2019-2025
44 companies · $868 in 2025
The $868 reported for 2025 was more than what 83% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,536 · 2020: $1,426 · 2021: $1,304 · 2022: $769 · 2023: $1,397 · 2024: $973 · 2025: $868.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,238.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,238.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,804.40 | 2019-2025 | Rybelsus, Ozempic |
| Astrazeneca Pharmaceuticals LP | $1,048.82 | 2019-2025 | Farxiga, Lokelma, Airsupra |
| Janssen Pharmaceuticals, INC | $1,006.04 | 2019-2023 | Xarelto |
| Smith+Nephew, INC. | $634.08 | 2019-2025 | Collagenase Santyl, Renasys Go V2 Home |
| Glaxosmithkline, LLC. | $528.78 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $490.34 | 2019-2025 | Jardiance, Synjardy |
| Organogenesis INC. | $367.84 | 2019-2025 | Puraply Wound Matrix, Puraply, Affinity |
| Amgen INC. | $282.13 | 2022-2024 | Repatha, Otezla |
| Merck Sharp & Dohme LLC | $190.72 | 2019-2021 | |
| Exact Sciences Corporation | $180.75 | 2024-2025 | Cologuard Collection Kit |
| Amarin Pharma, INC. | $180.43 | 2019-2021 | |
| Lilly USA, LLC | $179.52 | 2019-2025 | Mounjaro, Zepbound |
| Pfizer INC. | $177.64 | 2020-2024 | |
| Abbott Laboratories | $136.31 | 2019-2025 | Freestyle Libre 3 |
| Corcept Therapeutics | $132.57 | 2023-2025 | Korlym |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Rothberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.